Dorian LPG
LPG
YETI Holdings
YETI
Workday
WDAY
4
Collegium Pharmaceutical
COLL
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -37.87%133.5M | -37.87%133.5M | -56.32%144.39M | -40.58%169.4M | -45.98%251.77M | -38.28%214.89M | -38.28%214.89M | 25.84%330.55M | -42.72%285.09M | -0.22%466.1M |
-Cash and cash equivalents | -47.10%99.08M | -47.10%99.08M | -62.94%113.92M | -41.43%148.21M | -45.48%232.51M | -38.88%187.3M | -38.88%187.3M | 36.27%307.37M | -45.11%253.06M | -3.94%426.5M |
-Restricted cash and investments | 24.78%34.43M | 24.78%34.43M | 31.42%30.47M | -33.87%21.19M | -51.37%19.26M | -33.85%27.59M | -33.85%27.59M | -37.53%23.18M | -12.78%32.04M | 71.13%39.6M |
Net loan | -12.95%6.22B | -12.95%6.22B | -7.80%6.47B | -9.54%6.71B | -9.04%6.81B | -2.86%7.15B | -2.86%7.15B | -3.62%7.01B | 5.17%7.42B | 4.88%7.48B |
-Gross loan | -11.32%6.47B | -11.32%6.47B | -6.42%6.7B | -8.08%6.91B | -8.31%6.98B | -2.62%7.29B | -2.62%7.29B | -2.47%7.16B | 5.75%7.52B | 5.69%7.61B |
-Allowance for loans and lease losses | 70.00%243.03M | 70.00%243.03M | 61.81%229.27M | 96.58%203.76M | 34.25%171.34M | 11.12%142.96M | 11.12%142.96M | 139.38%141.69M | 74.50%103.65M | 94.53%127.63M |
Long term equity investment | -0.36%42.32M | -0.36%42.32M | -0.36%42.36M | -0.35%42.4M | -2.31%42.44M | 1.42%42.47M | 1.42%42.47M | 4.38%42.52M | --42.55M | --43.44M |
Foreclosed assets | -75.69%127.14M | -75.69%127.14M | -0.78%516.43M | -0.71%518.72M | 30.32%521.03M | 30.35%522.96M | 30.35%522.96M | 29.21%520.5M | 29.09%522.43M | -1.27%399.81M |
Assets held for sale | --307.02M | --307.02M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other assets | -4.50%132.65M | -4.50%132.65M | -1.90%137.96M | 8.25%144.55M | 46.04%133.14M | 54.58%138.91M | 54.58%138.91M | 90.55%140.63M | 117.42%133.53M | 40.57%91.16M |
Total assets | -13.66%6.97B | -13.66%6.97B | -9.20%7.31B | -9.71%7.58B | -8.59%7.76B | -2.09%8.07B | -2.09%8.07B | -0.12%8.05B | 4.80%8.4B | 5.10%8.48B |
Liabilities | ||||||||||
Federal funds purchased and securities sold under agreement to repurchase | -16.17%3.19B | -16.17%3.19B | -9.51%3.45B | -10.47%3.62B | -12.42%3.6B | -4.06%3.81B | -4.06%3.81B | -4.51%3.81B | 3.20%4.04B | 2.29%4.11B |
Payables | -39.48%27.02M | -39.48%27.02M | -28.06%32.28M | -28.22%44.55M | -29.53%44.83M | -27.84%44.64M | -27.84%44.64M | -27.80%44.87M | -0.38%62.07M | 3.48%63.62M |
-Dividends payable | --0 | --0 | -59.84%14.19M | -32.20%35.54M | -32.02%35.62M | -32.06%35.33M | -32.06%35.33M | -32.34%35.33M | -0.06%52.42M | 1.42%52.4M |
-Other payable | 190.07%27.02M | 190.07%27.02M | 89.60%18.09M | -6.53%9.01M | -17.87%9.21M | -5.59%9.32M | -5.59%9.32M | -3.90%9.54M | -2.05%9.64M | 14.35%11.21M |
Long term debt and capital lease obligation | -9.24%1.7B | -9.24%1.7B | -8.48%1.68B | -6.96%1.7B | 2.38%1.85B | 10.29%1.87B | 10.29%1.87B | 29.77%1.84B | 30.91%1.83B | 34.80%1.81B |
-Long term debt | -9.24%1.7B | -9.24%1.7B | -8.48%1.68B | -6.96%1.7B | 2.38%1.85B | 10.29%1.87B | 10.29%1.87B | 29.77%1.84B | 30.91%1.83B | 34.80%1.81B |
Other liabilities | -9.85%42.7M | -9.85%42.7M | -29.02%41.16M | -30.25%43.18M | -23.67%44.37M | -20.02%47.37M | -20.02%47.37M | 10.27%57.98M | 37.07%61.91M | -19.23%58.13M |
Total liabilities | -14.05%4.96B | -14.05%4.96B | -9.52%5.2B | -9.78%5.41B | -8.28%5.54B | -0.27%5.77B | -0.27%5.77B | 4.15%5.75B | 10.59%6B | 9.95%6.04B |
Shareholders'equity | ||||||||||
Share capital | 0.50%1.39M | 0.50%1.39M | -0.43%1.39M | -0.71%1.39M | -0.93%1.39M | -0.93%1.39M | -0.93%1.39M | 0.00%1.4M | 0.00%1.4M | 0.00%1.4M |
-common stock | 0.50%1.39M | 0.50%1.39M | -0.43%1.39M | -0.71%1.39M | -0.93%1.39M | -0.93%1.39M | -0.93%1.39M | 0.00%1.4M | 0.00%1.4M | 0.00%1.4M |
Paid-in capital | 0.54%2.74B | 0.54%2.74B | 0.53%2.74B | 0.44%2.73B | 0.51%2.73B | 0.48%2.73B | 0.48%2.73B | 0.16%2.72B | -0.10%2.72B | -0.27%2.72B |
Retained earnings | -71.86%-733.32M | -71.86%-733.32M | -48.71%-632.62M | -75.07%-562.22M | -88.71%-515.12M | -65.87%-426.7M | -65.87%-426.7M | -132.99%-425.42M | -86.23%-321.14M | -48.99%-272.97M |
Total stockholders'equity | -12.69%2.01B | -12.69%2.01B | -8.39%2.1B | -9.54%2.17B | -9.34%2.22B | -6.37%2.3B | -6.37%2.3B | -9.41%2.3B | -5.94%2.4B | -3.82%2.44B |
Total equity | -12.69%2.01B | -12.69%2.01B | -8.39%2.1B | -9.54%2.17B | -9.34%2.22B | -6.37%2.3B | -6.37%2.3B | -9.41%2.3B | -7.33%2.4B | -5.24%2.44B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |